4.6 Article

The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in rats

Journal

FRONTIERS IN NEUROSCIENCE
Volume 8, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fnins.2014.00003

Keywords

hypocretins/orexins; cognitive impairment; memory impairment; hypnotics; water maze; spatial reference memory; spatial working memory; EEG

Categories

Funding

  1. USAMRMC [W81XVVH-09-2-0081]

Ask authors/readers for more resources

The hypocretin receptor (HcrtR) antagonist almorexant (ALM) has potent hypnotic actions but little is known about neurocognitive performance in the presence of ALM. HcrtR antagonists are hypothesized to induce sleep by disfacilitation of wake-promoting systems whereas GABAA receptor modulators such as zolpidem (ZOL) induce sleep through general inhibition of neural activity. To test the hypothesis that less functional impairment results from HcrtR antagonist-induced sleep, we evaluated the performance of rats in the Morris Water Maze in the presence of ALM vs. ZOL. Performance in spatial reference memory (SRM) and spatial working memory (SVVM) tasks were assessed during the dark period after equipotent sleep-promoting doses (100 mg/kg, po) following undisturbed and sleep deprivation (SD) conditions. ALM-treated rats were indistinguishable from vehicle (VEH)-treated rats for all SRM performance measures (distance traveled, latency to enter, time within, and number of entries into, the target quadrant) after both the undisturbed and 6 h SD conditions. In contrast, rats administered ZOL showed impairments in all parameters measured compared to VEH or ALM in the undisturbed conditions. Following SD, ZOLtreated rats also showed impairments in all measures. ALM-treated rats were similar to VEH-treated rats for all SVVM measures (velocity, time to locate the platform and success rate at finding the platform within 60s) after both the undisturbed and SD conditions. In contrast, ZOLtreated rats showed impairments in velocity and in the time to locate the platform. Importantly, ZOL rats only completed the task 23-50% of the time while ALM and VEH rats completed the task 79-100% of the time. Thus, following equipotent sleep-promoting doses, ZOL impaired rats in both memory tasks while ALM rats performed at levels comparable to VEH rats. These results are consistent with the hypothesis that less impairment results from HcrtR antagonism than from GABAA-induced inhibition.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Cntnap2 Knockout Rats and Mice Exhibit Epileptiform Activity and Abnormal Sleep-Wake Physiology

Alexia M. Thomas, Michael D. Schwartz, Michael D. Saxe, Thomas S. Kilduff

SLEEP (2017)

Article Neurosciences

Excitation of Cortical nNOS/NK1R Neurons by Hypocretin 1 is Independent of Sleep Homeostasis

Rhiannan H. Williams, Sarah W. Black, Alexia M. Thomas, Juliette Piquet, Bruno Cauli, Thomas S. Kilduff

CEREBRAL CORTEX (2019)

Article Pharmacology & Pharmacy

Deletion of Trace Amine-Associated Receptor 1 Attenuates Behavioral Responses to Caffeine

Michael D. Schwartz, Jeremiah B. Palmerston, Diana L. Lee, Marius C. Hoener, Thomas S. Kilduff

FRONTIERS IN PHARMACOLOGY (2018)

Review Clinical Neurology

Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy

Steven T. Szabo, Michael J. Thorpy, Geert Mayer, John H. Peever, Thomas S. Kilduff

SLEEP MEDICINE REVIEWS (2019)

Article Neurosciences

Trace amine-associated receptor 1 agonism promotes wakefulness without impairment of cognition in Cynomolgus macaques

Anushka V. Goonawardena, Stephen R. Morairty, Ryan Dell, Gabriel A. Orellana, Marius C. Hoener, Tanya L. Wallace, Thomas S. Kilduff

NEUROPSYCHOPHARMACOLOGY (2019)

Article Multidisciplinary Sciences

REM sleep-active MCH neurons are involved in forgetting hippocampus-dependent memories

Shuntaro Izawa, Srikanta Chowdhury, Toh Miyazaki, Yasutaka Mukai, Daisuke Ono, Ryo Inoue, Yu Ohmura, Hiroyuki Mizoguchi, Kazuhiro Kimura, Mitsuhiro Yoshioka, Akira Terao, Thomas S. Kilduff, Akihiro Yamanaka

SCIENCE (2019)

Article Neurosciences

Transgenic Archaerhodopsin-3 Expression in Hypocretin/Orexin Neurons Engenders Cellular Dysfunction and Features of Type 2 Narcolepsy

Rhiannan H. Williams, Tomomi Tsunematsu, Alexia M. Thomas, Kelsie Bogyo, Akihiro Yamanaka, Thomas S. Kilduff

JOURNAL OF NEUROSCIENCE (2019)

Review Physiology

Shallow metabolic depression and human spaceflight: a feasible first step

Matthew D. Regan, Erin E. Flynn-Evans, Yuri V. Griko, Thomas S. Kilduff, Jon C. Rittenberger, Keith J. Ruskin, C. Loren Buck

JOURNAL OF APPLIED PHYSIOLOGY (2020)

Article Clinical Neurology

Acute cognitive effects of the hypocretin receptor antagonist almorexant relative to zolpidem and placebo: a randomized clinical trial

Thomas C. Neylan, Anne Richards, Thomas J. Metzler, Leslie M. Ruoff, Jonathan Varbel, Aoife O'Donovan, Melinda Sivasubramanian, Terri Motraghi, Jennifer Hlavin, Steven L. Batki, Sabra S. Inslicht, Kristin Samuelson, Stephen R. Morairty, Thomas S. Kilduff

SLEEP (2020)

Article Biology

Dual orexin and MCH neuron-ablated mice display severe sleep attacks and cataplexy

Chi Jung Hung, Daisuke Ono, Thomas S. Kilduff, Akihiro Yamanaka

ELIFE (2020)

Article Clinical Neurology

Cerebrospinal fluid monoamine levels in central disorders of hypersomnolence

Lucie Barateau, Isabelle Jaussent, Julien Roeser, Claudio Ciardiello, Thomas S. Kilduff, Yves Dauvilliers

Summary: This study found no significant differences in levels of monoamines, their metabolites, and trace amines in the cerebrospinal fluid among patients with NT1, NT2/IH, and those without objective sleepiness. While most biomarkers were not associated with key clinical or neurophysiological parameters, a few were correlated with daytime sleepiness and high REM sleep propensity. These findings contribute to the understanding of the neurobiology of hypersomnolence in these disorders and suggest the need for further exploration.

SLEEP (2021)

Review Clinical Neurology

Animal models of narcolepsy and the hypocretin/orexin system: Past, present, and future

Ryan K. Tisdale, Akihiro Yamanaka, Thomas S. Kilduff

Summary: Animal models have played a crucial role in investigating the etiology and phenotype of narcolepsy, revealing the relationship between the hypocretin/orexin system and narcolepsy. Additionally, these models have helped us understand the mechanisms of sleep/wake regulation.

SLEEP (2021)

Article Clinical Neurology

The development of sleep/wake disruption and cataplexy as hypocretin/orexin neurons degenerate in male vs. female Orexin/tTA; TetO-DTA Mice

Yu Sun, Ryan Tisdale, Sunmee Park, Shun-Chieh Ma, Jasmine Heu, Meghan Haire, Giancarlo Allocca, Akihiro Yamanaka, Stephen R. Morairty, Thomas S. Kilduff

Summary: This study compared the development of narcoleptic symptomatology in male and female mice with narcolepsy type 1. The study found that female mice showed characteristic symptoms of NT1 as early as the first week after the removal of doxycycline (DOX), while male mice did not consistently show these symptoms until the second week. By the second week, both sexes exhibited impaired ability to sustain wakefulness, lower subcutaneous temperature regulation, and the appearance of the Delta State.

SLEEP (2022)

Article Neurosciences

Parallel Arousal Pathways in the Lateral Hypothalamus

Jaime E. Heiss, Akihiro Yamanaka, Thomas S. Kilduff

ENEURO (2018)

Article Neurosciences

Cortical nNOS/NK1 Receptor Neurons are Regulated by Cholinergic Projections From the Basal Forebrain

Rhiannan H. Williams, Jacqueline Vazquez-DeRose, Alexia M. Thomas, Juliette Piquet, Bruno Cauli, Thomas S. Kilduff

CEREBRAL CORTEX (2018)

No Data Available